Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Psychiatry Research and Reviews
  4. Volume 21, Issue 3
  5. Article
Volume 21, Issue 3
  • ISSN: 2666-0822
  • E-ISSN: 2666-0830

Abstract

Background

In psychiatry, anxiety disorders are the most prevalent conditions and a major contributor to disability, along with immunosuppression, endocrine conditions like diabetes mellitus and male impotence, cognitive impairments, cardiovascular disease, hypertension, peptic ulcer, migraine, and Alzheimer's disease. Anxiety and depression continue to be the leading causes of death.

Objectives

This study presents data on the use of complementary and alternative therapies to treat anxiety.

Methods

SciFinder, Web of Science, Google Scholar, and PubMed were used to gather literature.

Results

It has been observed that complementary and alternative therapies are used more than conventional therapies by people with self-defined anxiety attacks and severe depression. Most patients visiting conventional mental health providers for these problems also use complementary and alternative therapies. The evidence for the most effective integrative health methods for treating anxiety disorder is presented in this review, with a focus on the use of herbal medicine. Anxiety can be treated using a variety of psychotherapies as well as antidepressant medication, but the risks of overconsumption, as well as interactions with prescription medications and other drugs, are also factors to consider the herbal therapy.

Conclusion

This review highlights the management and treatment of anxiety. However, further larger-scale studies on alternative treatments are required.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cprr/10.2174/0126660822265289240306175345
2024-03-14
2025-05-12

  • From This Site

    /content/journals/cprr/10.2174/0126660822265289240306175345
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WatsonD. ClarkL.A. CareyG. Positive and negative affectivity and their relation to anxiety and depressive disorders.J. Abnorm. Psychol.198897334635310.1037/0021‑843X.97.3.346 3192830
     [Google Scholar]
  2. AllenJ.L. LavalleeK.L. HerrenC. RuheK. SchneiderS. DSM-IV criteria for childhood separation anxiety disorder: Informant, age, and sex differences.J. Anxiety Disord.201024894695210.1016/j.janxdis.2010.06.022 20675099
     [Google Scholar]
  3. JacobS. NairA.B. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs.Drugs R D.201616430331610.1007/s40268‑016‑0148‑6 27766590
     [Google Scholar]
  4. GottschalkM.G. DomschkeK. Genetics of generalized anxiety disorder and related traits.Dialogues Clin. Neurosci.201719215916810.31887/DCNS.2017.19.2/kdomschke 28867940
     [Google Scholar]
  5. ChildsE. de WitH. Effects of acute psychosocial stress on cigarette craving and smoking.Nicotine Tob. Res.201012444945310.1093/ntr/ntp214 20100807
     [Google Scholar]
  6. GaleC.K. MillichampJ. Generalised anxiety disorder in children and adolescents.Clin. Evid.201620161002 26763675
     [Google Scholar]
  7. StaleyD. WandR.R. Obsessive-compulsive disorder: A review of the cross-cultural epidemiological literature.Transcult. Psychiatry1995322103136
     [Google Scholar]
  8. DaltonE.D. HammenC.L. Independent and relative effects of stress, depressive symptoms, and affect on college students’ daily health behaviors.J. Behav. Med.201841686387410.1007/s10865‑018‑9945‑4 29926314
     [Google Scholar]
  9. van der MeerD. HoekstraP.J. van DonkelaarM. Predicting attention-deficit/hyperactivity disorder severity from psychosocial stress and stress-response genes: A random forest regression approach.Transl. Psychiatry201776e114510.1038/tp.2017.114 28585928
     [Google Scholar]
  10. ZieglerC. SchieleM.A. DomschkeK. Patho- und therapieepigenetik psychischer erkrankungen [Patho- and therapyepigenetics of mental disorders.Nervenarzt201889111303131410.1007/s00115‑018‑0625‑y
     [Google Scholar]
  11. KaczkurkinA.N. FoaE.B. Cognitive-behavioral therapy for anxiety disorders: An update on the empirical evidence.Dialogues Clin. Neurosci.201517333734610.31887/DCNS.2015.17.3/akaczkurkin 26487814
     [Google Scholar]
  12. Welton-MitchellC. JamesL.E. KhanalS.N. JamesA.S. An integrated approach to mental health and disaster preparedness: A cluster comparison with earthquake affected communities in Nepal.BMC Psychiatry201818129610.1186/s12888‑018‑1863‑z 30223822
     [Google Scholar]
  13. ChenL. ZhangX. HuC. Regulation of GABAA and 5-HT receptors involved in anxiolytic mechanisms of jujube seed: A system biology study assisted by UPLC-Q-TOF/MS and RT-qPCR method.Front. Pharmacol.2020110132010.3389/fphar.2020.01320 33178009
     [Google Scholar]
  14. HossainT. AhammedB. ChandaS.K. JahanN. ElaM.Z. IslamN. Social and electronic media exposure and generalized anxiety disorder among people during COVID-19 outbreak in Bangladesh: A preliminary observation.PLoS One2020159e0238974
     [Google Scholar]
  15. BaldaçaraL. da SilvaA.G. PereiraL.A. Malloy-DinizL. TungT.C. The management of psychiatric emergencies in situations of public calamity.Front. Psychiatry20211255679210.3389/fpsyt.2021.556792 33643085
     [Google Scholar]
  16. ParkH. Evolutionary ecological model of defence activation disorders via the marginal value theorem.Psychiatry Investig.202017655657810.30773/pi.2020.0051 32450621
     [Google Scholar]
  17. CuiQ. ShengW. ChenY. Dynamic changes of amplitude of low‐frequency fluctuations in patients with generalized anxiety disorder.Hum. Brain Mapp.20204161667167610.1002/hbm.24902 31849148
     [Google Scholar]
  18. StarrL.R. DavilaJ. Temporal patterns of anxious and depressed mood in generalized anxiety disorder: A daily diary study.Behav. Res. Ther.201250213114110.1016/j.brat.2011.11.005 22196213
     [Google Scholar]
  19. ToussaintA. HüsingP. GumzA. Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7).J. Affect. Disord.202026539540110.1016/j.jad.2020.01.032 32090765
     [Google Scholar]
  20. OlivierJ.D.A. OlivierB. Translational studies in the complex role of neurotransmitter systems in anxiety and anxiety disorders.Adv. Exp. Med. Biol.2020119112114010.1007/978‑981‑32‑9705‑0_8 32002926
     [Google Scholar]
  21. WorsleyJ.D. McIntyreJ.C. BentallR.P. CorcoranR. Childhood maltreatment and problematic social media use: The role of attachment and depression.Psychiatry Res.2018267889310.1016/j.psychres.2018.05.023 29886276
     [Google Scholar]
  22. ReardonC.L. GorczynskiP. HainlineB. HitchcockM. RiceS. Anxiety disorders in athletes.Clin. Sports Med.2024431335210.1016/j.csm.2023.06.002 37949513
     [Google Scholar]
  23. SteinD.J. CostaD.L.C. LochnerC. Obsessive–compulsive disorder.Nat. Rev. Dis. Primers2019515210.1038/s41572‑019‑0102‑3 31371720
     [Google Scholar]
  24. DomschkeK. ReifA. Behavioral genetics of affective and anxiety disorders.Curr. Top. Behav. Neurosci.20111246350210.1007/7854_2011_185 22307738
     [Google Scholar]
  25. DomschkeK. MaronE. Genetic factors in anxiety disorders.Mod. Trends Pharmacopsychiatry2013292446 25225016
     [Google Scholar]
  26. GuevaraA. Clinical practice want more papers like this?Mass Med Soc20153732120592068
     [Google Scholar]
  27. PostuP.A. MihasanM. GorganD.L. SadikiF.Z. El IdrissiM. HritcuL. Pinus halepensis essential oil ameliorates Aβ1-42-induced brain injury by diminishing anxiety, oxidative stress, and neuroinflammation in rats.Biomedicines2022109230010.3390/biomedicines10092300 36140401
     [Google Scholar]
  28. BandelowB. SherL. BuneviciusR. Guidelines for the pharmacological treatment of anxiety disorders, obsessive–compulsive disorder and posttraumatic stress disorder in primary care.Int. J. Psychiatry Clin. Pract.2012162778410.3109/13651501.2012.667114 22540422
     [Google Scholar]
  29. ShinS.W. LeeJ.S. AbdiS. LeeS.J. KimK.H. Antipsychotics for patients with pain.Korean J. Pain201932131110.3344/kjp.2018.32.1.3 30671198
     [Google Scholar]
  30. SavageK. SarrisJ. HughesM. Neuroimaging insights: Kava’s (Piper methysticum) effect on dorsal anterior cingulate cortex gaba in generalized anxiety disorder.Nutrients20231521458610.3390/nu15214586 37960239
     [Google Scholar]
  31. Tovo-RodriguesL. QuinteG. BrumC. The role of MIR9-2 in shared susceptibility of psychiatric disorders during childhood: A population-based birth cohort study.Genes201910862610.3390/genes10080626 31434288
     [Google Scholar]
  32. KesslerR.C. BerglundP. DemlerO. JinR. MerikangasK.R. WaltersE.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication.Arch. Gen. Psychiatry200562659360210.1001/archpsyc.62.6.593 15939837
     [Google Scholar]
  33. BystritskyA. Treatment-resistant anxiety disorders.Mol. Psychiatry200611980581410.1038/sj.mp.4001852 16847460
     [Google Scholar]
  34. NardiA.E. FreireR.C.R. Panic disorder: Neurobiological and treatment aspects.Panic Disorder: Neurobiological and Treatment Aspects.Springer International Publishing20161312
     [Google Scholar]
  35. WilliamsT. HattinghC.J. KariukiC.M. Pharmacotherapy for social anxiety disorder (SAnD).Cochrane Libr.201720191CD00120610.1002/14651858.CD001206.pub3 29048739
     [Google Scholar]
  36. Salvia-TrujilloL. McClementsD.J. Improvement of β-carotene bioaccessibility from dietary supplements using excipient nanoemulsions.J. Agric. Food Chem.201664224639464710.1021/acs.jafc.6b00804 27198626
     [Google Scholar]
  37. CraskeM.G. SteinM.B. Anxiety.Lancet2016388100633048305910.1016/S0140‑6736(16)30381‑6
     [Google Scholar]
  38. MishraA.K. VarmaA.R. A comprehensive review of the generalized anxiety disorder.Cureus2023159e4611510.7759/cureus.46115 37900518
     [Google Scholar]
  39. GoodmanF.R. KashdanT.B. İmamoğluA. Valuing emotional control in social anxiety disorder: A multimethod study of emotion beliefs and emotion regulation.Emotion202121484285510.1037/emo0000750 32191093
     [Google Scholar]
  40. NorwitzN.G. NaidooU. Nutrition as metabolic treatment for anxiety.Front. Psychiatry20211259811910.3389/fpsyt.2021.598119 33643090
     [Google Scholar]
  41. KirmiziogluY. DoğanO. KuğuN. AkyüzG. Prevalence of anxiety disorders among elderly people.Int. J. Geriatr. Psychiatry20092491026103310.1002/gps.2215 19259977
     [Google Scholar]
  42. ChildressA.C. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.Adv. Ther.201229538540010.1007/s12325‑012‑0020‑1 22610723
     [Google Scholar]
  43. CuijpersP. GentiliC. BanosR.M. Garcia-CampayoJ. BotellaC. CristeaI.A. Relative effects of cognitive and behavioral therapies on generalized anxiety disorder, social anxiety disorder and panic disorder: A meta-analysis.J. Anxiety Disord.201643798910.1016/j.janxdis.2016.09.003 27637075
     [Google Scholar]
  44. AtoD. SawayamaT. Factors associated with high brachial–ankle pulse wave velocity in non-hypertensive and appropriately treated hypertensive patients with atherosclerotic risk factors.Vasc. Health Risk Manag.20171338339210.2147/VHRM.S144923 29066906
     [Google Scholar]
  45. FujiwaraH. NakajimaH. InoueF. KosakaK. AsanoH. YoshiiK. Arterial stiffness in junior high school students: Longitudinal observations.Pediatr. Int.201860212713510.1111/ped.13475 29230906
     [Google Scholar]
  46. HalldorssonB. DraiseyJ. CooperP. CreswellC. Symptoms of social anxiety, depression, and stress in parents of children with social anxiety disorder.Br. J. Clin. Psychol.201857214816210.1111/bjc.12170 29336041
     [Google Scholar]
  47. EmmelkampP.M.G. MeyerbrökerK. MorinaN. Virtual reality therapy in social anxiety disorder.Curr. Psychiatry Rep.20202273210.1007/s11920‑020‑01156‑1 32405657
     [Google Scholar]
  48. PernaG. AlciatiA. RivaA. MicieliW. CaldirolaD. Long-term pharmacological treatments of anxiety disorders: An updated systematic review.Curr. Psychiatry Rep.20161832310.1007/s11920‑016‑0668‑3 26830881
     [Google Scholar]
  49. BandelowB. Current and novel psychopharmacological drugs for anxiety disorders.Adv. Exp. Med. Biol.2020119134736510.1007/978‑981‑32‑9705‑0_19 32002937
     [Google Scholar]
  50. KumarD. BhatZ.A. KumarV. RajaW.Y. ShahM.Y. Anti-anxiety activity of Stachys tibetica Vatke.Chin. J. Nat. Med.201311324024410.1016/S1875‑5364(13)60022‑9 23725835
     [Google Scholar]
  51. YeeA. NgC.G. SengL.H. Vortioxetine treatment for anxiety disorder: A meta-analysis study.Curr. Drug Targets201819121412142310.2174/1389450118666171117131151 29149828
     [Google Scholar]
  52. LealP.C. GoesT.C. da SilvaL.C.F. Teixeira-SilvaF. Ansiedade traço versus ansiedade estado em diferentes situações de ameaça.Trends Psychiatry Psychother.201739314715710.1590/2237‑6089‑2016‑0044 28813110
     [Google Scholar]
  53. MulaM. PiniS. CassanoG.B. The role of anticonvulsant drugs in anxiety disorders: a critical review of the evidence.J. Clin. Psychopharmacol.200727326327210.1097/jcp.0b013e318059361a 17502773
     [Google Scholar]
  54. HirschfeldR.M.A. WeislerR.H. RainesS.R. MacfaddenW. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: A secondary analysis from a randomized, double-blind, placebo-controlled study.J. Clin. Psychiatry200667335536210.4088/JCP.v67n0304 16649820
     [Google Scholar]
  55. RosenbergH. PollockN. SchiemannA. BulgerT. StowellK. Malignant hyperthermia: A review.Orphanet J. Rare Dis.20151019310.1186/s13023‑015‑0310‑1 26238698
     [Google Scholar]
  56. BeiterR. NashR. McCradyM. The prevalence and correlates of depression, anxiety, and stress in a sample of college students.J. Affect. Disord.2015173909610.1016/j.jad.2014.10.054 25462401
     [Google Scholar]
  57. JonesC. BarreraI. BrothersS. RingR. WahlestedtC. Oxytocin and social functioning.Dialogues Clin. Neurosci.201719219320110.31887/DCNS.2017.19.2/cjones 28867943
     [Google Scholar]
  58. NeumannI.D. VeenemaA.H. BeiderbeckD.I. Aggression and anxiety: Social context and neurobiological links.Front. Behav. Neurosci.201041210.3389/fnbeh.2010.00012 20407578
     [Google Scholar]
  59. NeumannI.D. Brain oxytocin: A key regulator of emotional and social behaviours in both females and males.J. Neuroendocrinol.200820685886510.1111/j.1365‑2826.2008.01726.x 18601710
     [Google Scholar]
  60. ThibautF. Anxiety disorders: A review of current literature.Dialogues Clin. Neurosci.2017192878810.31887/DCNS.2017.19.2/fthibaut 28867933
     [Google Scholar]
  61. GoodwinG.M. SteinD.J. Generalised anxiety disorder and depression: Contemporary treatment approaches.Adv. Ther.202138S2Suppl. 2455110.1007/s12325‑021‑01859‑8 34417991
     [Google Scholar]
  62. BrungerA.T. ChoiU.B. LaiY. LeitzJ. ZhouQ. Molecular mechanisms of fast neurotransmitter release.Annu. Rev. Biophys.201847146949710.1146/annurev‑biophys‑070816‑034117 29792815
     [Google Scholar]
  63. WanM. DingL. WangD. HanJ. GaoP. Serotonin: A potent immune cell modulator in autoimmune diseases.Front. Immunol.20201118610.3389/fimmu.2020.00186 32117308
     [Google Scholar]
  64. PostilaP.A. RógT. A perspective: Active role of lipids in neurotransmitter dynamics.Mol. Neurobiol.202057291092510.1007/s12035‑019‑01775‑7 31595461
     [Google Scholar]
  65. ParkC. RosenblatJ.D. BrietzkeE. Stress, epigenetics and depression: A systematic review.Neurosci. Biobehav. Rev.201910213915210.1016/j.neubiorev.2019.04.010 31005627
     [Google Scholar]
  66. BaldacchinoA.M. SharmaB. Substance-induced mental disorders.Textbook of Addiction Treatment.ChamSpringer International Publishing202112871295http://link.springer.com/10.1007/978-3-030-36391-8_90 Internet10.1007/978‑3‑030‑36391‑8_90
     [Google Scholar]
  67. ChanG. ConnorJ. HallW. LeungJ. The changing patterns and correlates of population‐level polysubstance use in Australian youth: A multi‐group latent class analysis of nationally representative samples spanning 12 years.Addiction2020115114515510.1111/add.14761 31357251
     [Google Scholar]
  68. El YacoubiM CostentinJ VaugeoisJM Adenosine A 2A receptors and depression.Neurology200361(11_suppl_6)(Suppl. 6): S82-7. http://dx.doi.org/10.1212/01.WNL.0000095220.87550.F6 14663017
     [Google Scholar]
  69. WatsonD. ClarkL.A. TellegenA. Development and validation of brief measures of positive and negative affect: The PANAS scales.J. Pers. Soc. Psychol.19885461063107010.1037/0022‑3514.54.6.1063 3397865
     [Google Scholar]
  70. LockeA.B. KirstN. ShultzC.G. Diagnosis and management of generalized anxiety disorder and panic disorder in adults.Am. Fam. Physician2015919617624 25955736
     [Google Scholar]
  71. SilvaC. SiqueiraL. DragoL.C. LinsE.M.F. MartinsD.F. BobinskiF. Effects of auriculotherapy on anxiety and biomarkers in primary health care: A clinical trial.Rev. Bras. Enferm.2023766e2022072810.1590/0034‑7167‑2022‑0728pt 38055476
     [Google Scholar]
  72. BerkingM. WuppermanP. ReichardtA. PejicT. DippelA. ZnojH. Emotion-regulation skills as a treatment target in psychotherapy.Behav. Res. Ther.200846111230123710.1016/j.brat.2008.08.005 18835479
     [Google Scholar]
  73. BeharE. DiMarcoI.D. HeklerE.B. MohlmanJ. StaplesA.M. Current theoretical models of generalized anxiety disorder (GAD): Conceptual review and treatment implications.J. Anxiety Disord.20092381011102310.1016/j.janxdis.2009.07.006 19700258
     [Google Scholar]
  74. McDermottB.M. CobhamV.E. A stepped-care model of post-disaster child and adolescent mental health service provision.Eur. J. Psychotraumatol.2014512429410.3402/ejpt.v5.24294 25045422
     [Google Scholar]
  75. EyreO. LangleyK. StringarisA. LeibenluftE. CollishawS. ThaparA. Irritability in ADHD: Associations with depression liability.J. Affect. Disord.201721528128710.1016/j.jad.2017.03.050 28363151
     [Google Scholar]
  76. SciberrasE. EfronD. PatelP. Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial.BMC Psychiatry201919135910.1186/s12888‑019‑2276‑3 31722690
     [Google Scholar]
  77. KellyJ.M. RubenfeldG.D. MassonN. MinA. AdhikariN.K.J. Using selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in critical care: A systematic review of the evidence for benefit or harm.Crit. Care Med.2017456e607e61610.1097/CCM.0000000000002308 28338497
     [Google Scholar]
  78. KarkowD.C. KauerJ.F. ErnstE.J. Incidence of serotonin syndrome with combined use of linezolid and serotonin reuptake inhibitors compared with linezolid monotherapy.J. Clin. Psychopharmacol.201737551852310.1097/JCP.0000000000000751 28796019
     [Google Scholar]
  79. HafidhR.R. AbdulamirA.S. BakarF.A. JalilianF.A. AbasF. SekawiZ. Novel molecular, cytotoxical, and immunological study on promising and selective anticancer activity of Mung bean sprouts.BMC Complement. Altern. Med.201212120810.1186/1472‑6882‑12‑208 23122182
     [Google Scholar]
  80. VaughnA.R. PourangA. ClarkA.K. BurneyW. SivamaniR.K. Dietary supplementation with turmeric polyherbal formulation decreases facial redness: A randomized double-blind controlled pilot study.J. Integr. Med.2019171202310.1016/j.joim.2018.11.004 30527287
     [Google Scholar]
  81. FeinbergT. WielandL.S. MillerL.E. Polyherbal dietary supplementation for prediabetic adults: study protocol for a randomized controlled trial.Trials20192012410.1186/s13063‑018‑3032‑6 30616613
     [Google Scholar]
  82. SaleemU. UsmanM. AnwarF. AkhtarM.F. AhmadB. Pharmacological and toxicological evaluation of two anti-asthmatic polyherbal formulations.An. Acad. Bras. Cienc.2020923e2019156210.1590/0001‑3765202020191562 33053107
     [Google Scholar]
  83. SuvarnaR. ShenoyR.P. HadapadB.S. NayakA.V. Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis.J. Ayurveda Integr. Med.202112121322210.1016/j.jaim.2020.11.002 33551339
     [Google Scholar]
  84. TalaeiA. ForouzanfarF. AkhondzadehS. Medicinal plants in the treatment of obsessive-compulsive disorder: A review.Curr. Drug Discov. Technol.202118181610.2174/1570163816666191011105050 31660838
     [Google Scholar]
  85. DhawanK. KumarS. SharmaA. Reversal of cannabinoids (Δ9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: A possible therapy for cannabinoid addiction.J. Pharm. Pharmacol.201054687588110.1211/0022357021779069 12079005
     [Google Scholar]
  86. BreuerA. HajC.G. FogaçaM.V. Fluorinated cannabidiol derivatives: Enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects.PLoS One2016117e015877910.1371/journal.pone.0158779 27416026
     [Google Scholar]
  87. BucknerJ.D. KeoughM.E. SchmidtN.B. Problematic alcohol and cannabis use among young adults: The roles of depression and discomfort and distress tolerance.Addict. Behav.20073291957196310.1016/j.addbeh.2006.12.019 17258398
     [Google Scholar]
  88. McPartlandJ.M. RussoE.B. Cannabis and cannabis extracts.J. Cannabis Ther.200113-410313210.1300/J175v01n03_08
     [Google Scholar]
  89. LakhanS.E. VieiraK.F. Nutritional and herbal supplements for anxiety and anxiety-related disorders: Systematic review.Nutr. J.2010914210.1186/1475‑2891‑9‑42 20929532
     [Google Scholar]
  90. KingD.E. MainousA.G.III GeeseyM.E. WoolsonR.F. Dietary magnesium and C-reactive protein levels.J. Am. Coll. Nutr.200524316617110.1080/07315724.2005.10719461 15930481
     [Google Scholar]
  91. SingapuraN. KandangathR. Anxiolytic property of hydro-alcohol extract of Lactuca sativa and its effect on behavioral activities of mice.J. Biomed. Res.2013271374210.7555/JBR.27.20120059 23554792
     [Google Scholar]
  92. DegefuT. Wolde-meskelE. RascheF. Genetic diversity and symbiotic effectiveness of Bradyrhizobium strains nodulating selected annual grain legumes growing in Ethiopia.Int. J. Syst. Evol. Microbiol.201868144946010.1099/ijsem.0.002486 29143730
     [Google Scholar]
  93. Ramos-RuizR. PoirotE. Flores-MosqueraM. GABA, a non-protein amino acid ubiquitous in food matrices.Cogent Food Agric.201841153432310.1080/23311932.2018.1534323
     [Google Scholar]
  94. DoQ.D. AngkawijayaA.E. Tran-NguyenP.L. Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica.J Food Drug Anal201422329630210.1016/j.jfda.2013.11.001 28911418
     [Google Scholar]
  95. SampathC. HolbikM. KrennL. ButterweckV. Anxiolytic effects of fractions obtained from Passiflora incarnata L. in the elevated plus maze in mice.Phytother. Res.201125678979510.1002/ptr.3332 21077264
     [Google Scholar]
  96. DengJ. ZhouY. BaiM. LiH. LiL. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa.J. Ethnopharmacol.2010128114815310.1016/j.jep.2009.12.043 20051259
     [Google Scholar]
  97. SarrisJ. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review.Phytother. Res.201832711471162
     [Google Scholar]
  98. MoragregaI. RíosJ.L. Medicinal plants in the treatment of depression: Evidence from preclinical studies.Planta Med.202187965668510.1055/a‑1338‑1011 33434941
     [Google Scholar]
  99. RamaholimihasoT. BouazzaouiF. KaladjianA. Curcumin in depression: Potential mechanisms of action and current evidence—a narrative review.Front. Psychiatry20201157253310.3389/fpsyt.2020.572533 33329109
     [Google Scholar]
  100. LewisJ.E. PolesJ. ShawD.P. The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.J. Clin. Transl. Res.202174575620 34541370
     [Google Scholar]
  101. Fusar-PoliL. VozzaL. GabbiadiniA. Curcumin for depression: A meta-analysis.Crit. Rev. Food Sci. Nutr.202060152643265310.1080/10408398.2019.1653260 31423805
     [Google Scholar]
  102. BhatA. MahalakshmiA.M. RayB. Benefits of curcumin in brain disorders.Biofactors201945566668910.1002/biof.1533 31185140
     [Google Scholar]
  103. HewlingsS. KalmanD. Curcumin: A review of its effects on human health.Foods20176109210.3390/foods6100092 29065496
     [Google Scholar]
  104. MessaoudiM. LalondeR. ViolleN. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects.Br. J. Nutr.2011105575576410.1017/S0007114510004319 20974015
     [Google Scholar]
  105. Ait-BelgnaouiA. ColomA. BranisteV. Probiotic gut effect prevents the chronic psychological stress‐induced brain activity abnormality in mice.Neurogastroenterol. Motil.201426451052010.1111/nmo.12295 24372793
     [Google Scholar]
  106. DinanT.G. StantonC. CryanJ.F. Psychobiotics: A novel class of psychotropic.Biol. Psychiatry2013741072072610.1016/j.biopsych.2013.05.001 23759244
     [Google Scholar]
  107. SinghB. SinghJ.P. ShevkaniK. SinghN. KaurA. Bioactive constituents in pulses and their health benefits.J. Food Sci. Technol.201754485887010.1007/s13197‑016‑2391‑9 28303037
     [Google Scholar]
  108. Wielgosz-GrochowskaJ.P. DomanskiN. DrywieńM.E. Efficacy of an irritable bowel syndrome diet in the treatment of small intestinal bacterial overgrowth: A narrative review.Nutrients20221416338210.3390/nu14163382 36014888
     [Google Scholar]
  109. ChengL. PanG. SunX. HuangY. PengY. ZhouL. Evaluation of anxiolytic-like effect of aqueous extract of asparagus stem in mice.Evid. Based Complement. Alternat. Med.2013201311010.1155/2013/587260 24348707
     [Google Scholar]
  110. MajumdarS. GuptaS. PrajapatiS.K. KrishnamurthyS. Neuro-nutraceutical potential of Asparagus racemosus: A review.Neurochem. Int.202114510501310.1016/j.neuint.2021.105013 33689806
     [Google Scholar]
  111. RamanathanM. BalajiB. JustinA. Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model.Indian J. Exp. Biol.2011494269275 21614890
     [Google Scholar]
  112. BoyleN.B. LawtonC.L. DyeL. The effects of magnesium supplementation on subjective anxiety.Magnes. Res.2016293120125 27869100
     [Google Scholar]
  113. ZhuC. ZhangY. WangT. Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency.Brain Behav.20201011e0176010.1002/brb3.1760 32945627
     [Google Scholar]
  114. KafeshaniM. FeiziA. EsmaillzadehA. Higher vitamin B 6 intake is associated with lower depression and anxiety risk in women but not in men: A large cross-sectional study.Int. J. Vitam. Nutr. Res.2020905-648449210.1024/0300‑9831/a000589 31188081
     [Google Scholar]
  115. OstadmohammadiV. JamilianM. BahmaniF. AsemiZ. Vitamin D and probiotic co-supplementation affects mental health, hormonal, inflammatory and oxidative stress parameters in women with polycystic ovary syndrome.J. Ovarian Res.2019121510.1186/s13048‑019‑0480‑x 30665436
     [Google Scholar]
  116. YoungL.M. PipingasA. WhiteD.J. GauciS. ScholeyA. A systematic review and meta-analysis of b vitamin supplementation on depressive symptoms, anxiety, and stress: Effects on healthy and ‘at-risk’ individuals.Nutrients2019119223210.3390/nu11092232 31527485
     [Google Scholar]
  117. MoritzB. SchmitzA.E. RodriguesA.L.S. DafreA.L. CunhaM.P. The role of vitamin C in stress-related disorders.J. Nutr. Biochem.20208510845910.1016/j.jnutbio.2020.108459 32745879
     [Google Scholar]
  118. KocotJ. Luchowska-KocotD. KiełczykowskaM. MusikI. KurzepaJ. Does vitamin c influence neurodegenerative diseases and psychiatric disorders?Nutrients20179765910.3390/nu9070659 28654017
     [Google Scholar]
  119. BičíkováM. DuškováM. VítkůJ. Vitamin D in anxiety and affective disorders.Physiol. Res.201564Suppl. 2S101S10310.33549/physiolres.933082 26680471
     [Google Scholar]
  120. CassebG.A.S. KasterM.P. RodriguesA.L.S. Potential role of Vitamin D for the management of depression and anxiety.CNS Drugs201933761963710.1007/s40263‑019‑00640‑4 31093951
     [Google Scholar]
  121. LambrinakouS. KatsaM.E. ZygaS. Correlations between nutrition habits, anxiety and metabolic parameters in greek healthy adults.Adv. Exp. Med. Biol.2017987233410.1007/978‑3‑319‑57379‑3_3 28971444
     [Google Scholar]
  122. JarpaE. BabulM. CalderónJ. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity.Lupus2011201586610.1177/0961203310381773 21078764
     [Google Scholar]
  123. Calderón-MontañoJ.M. Burgos-MorónE. Pérez-GuerreroC. López-LázaroM. A review on the dietary flavonoid kaempferol.Mini Rev. Med. Chem.201111429834410.2174/138955711795305335 21428901
     [Google Scholar]
  124. ZabelaV. SampathC. OufirM. Moradi-AfrapoliF. ButterweckV. HamburgerM. Pharmacokinetics of dietary kaempferol and its metabolite 4-hydroxyphenylacetic acid in rats.Fitoterapia201611518919710.1016/j.fitote.2016.10.008 27810397
     [Google Scholar]
  125. BruniO. Ferini-StrambiL. GiacomoniE. PellegrinoP. Herbal remedies and their possible effect on the GABAergic system and sleep.Nutrients202113253010.3390/nu13020530 33561990
     [Google Scholar]
  126. SavageK. FirthJ. StoughC. SarrisJ. GABA‐modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence.Phytother. Res.201832131810.1002/ptr.5940 29168225
     [Google Scholar]
  127. SharmaR. KabraA. RaoM.M. PrajapatiP.K. Herbal and holistic solutions for neurodegenerative and depressive disorders: Leads from ayurveda.Curr. Pharm. Des.201824222597260810.2174/1381612824666180821165741 30147009
     [Google Scholar]
  128. KamatD. Al-AjlouniY.A. HallR.C.W. The therapeutic impact of plant-based and nutritional supplements on anxiety, depressive symptoms and sleep quality among adults and elderly: A systematic review of the literature.Int. J. Environ. Res. Public Health2023206517110.3390/ijerph20065171 36982079
     [Google Scholar]
  129. RichardsS.H. AndersonL. JenkinsonC.E. Psychological interventions for coronary heart disease.Cochrane Libr.201720212CD00290210.1002/14651858.CD002902.pub4 28452408
     [Google Scholar]
  130. WeeksB.S. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.Med. Sci. Monit.20091511RA256RA262 19865069
     [Google Scholar]
  131. BhattacharyaS.K. BhattacharyaA. SairamK. GhosalS. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: An experimental study.Phytomedicine20007646346910.1016/S0944‑7113(00)80030‑6 11194174
     [Google Scholar]
  132. ChoudharyD. BhattacharyyaS. BoseS. Efficacy and safety of Ashwagandha (Withania somnifera (L.) Dunal) root extract in improving memory and cognitive functions.J. Diet. Suppl.201714659961210.1080/19390211.2017.1284970 28471731
     [Google Scholar]
  133. SinghN. BhallaM. De JagerP. GilcaM. An overview on ashwagandha: A Rasayana (rejuvenator) of Ayurveda.Afr. J. Tradit. Complement. Altern. Med.201185SSuppl.20821310.4314/ajtcam.v8i5S.9 22754076
     [Google Scholar]
  134. MadaanR. KumarS. BansalG. SharmaA. Estimation of total phenols and flavonoids in extracts of actaea spicata roots and antioxidant activity studies.Indian J. Pharm. Sci.201173666666910.4103/0250‑474X.100242 23112402
     [Google Scholar]
  135. UddinM.J. Ali RezaA.S.M. Abdullah-Al-MamunM. Antinociceptive and anxiolytic and sedative effects of methanol extract of anisomeles indica: an experimental assessment in mice and computer aided models.Front. Pharmacol.2018924610.3389/fphar.2018.00246 29706888
     [Google Scholar]
  136. ChangH.H. YiP.L. ChengC.H. Biphasic effects of baicalin, an active constituent of Scutellaria baicalensis Georgi, in the spontaneous sleep–wake regulation.J. Ethnopharmacol.2011135235936810.1016/j.jep.2011.03.023 21419210
     [Google Scholar]
  137. SenN BulbulL HussainMS BanikS ChoudhuriMSK An in vivo study regarding analgesic and anxiolytic activity of methanolic extract of Typha elephantina Roxb.Clin Phytoscience20184210.1186/s40816‑018‑0061‑3
     [Google Scholar]
  138. Díaz-de-CerioE. Aguilera-SaezL.M. Gómez-CaravacaA.M. Characterization of bioactive compounds of Annona cherimola L. leaves using a combined approach based on HPLC-ESI-TOF-MS and NMR.Anal. Bioanal. Chem.2018410153607361910.1007/s00216‑018‑1051‑5 29629503
     [Google Scholar]
  139. LandaverdeN. Anxiolytic and sedative effects of essential oil from Casimiroa pringlei on Wistar rats.J. Med. Plants Res.2019310791798
     [Google Scholar]
  140. Molina-HernándezM. Tellez-AlcántaraN.P. Pérez GarcíaJ. LopezJ.I.O. JaramilloM.T. Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats.J. Ethnopharmacol.2004931939810.1016/j.jep.2004.03.039 15182911
     [Google Scholar]
  141. GutiérrezG. Sedative activity of some plants used in Mexico to treat insomnia.Rev Latinoamer Quím200937
     [Google Scholar]
  142. MoraS. Diaz-VelizG. LungenstrassH. Central nervous system activity of the hydroalcoholic extract of Casimiroa edulis in rats and mice.J. Ethnopharmacol.200597219119710.1016/j.jep.2004.10.028 15707751
     [Google Scholar]
  143. SarrisJ. McIntyreE. CamfieldD.A. Plant-based medicines for anxiety disorders, Part 1: A review of preclinical studies.CNS Drugs201327320721910.1007/s40263‑013‑0044‑3 23436255
     [Google Scholar]
  144. BhandariR. GyawaliS. AryalN. Evaluation of phytochemical, antioxidant, and memory-enhancing activity of Garuga pinnata Roxb. Bark and Bryophyllum pinnatum (Lam) Oken. leaves.ScientificWorldJournal202120211710.1155/2021/6649574 33994883
     [Google Scholar]
  145. KallelI. HadrichB. GargouriB. Optimization of cinnamon (Cinnamomum zeylanicum Blume) essential oil extraction: evaluation of antioxidant and antiproliferative effects.Evid. Based Complement. Alternat. Med.2019201911110.1155/2019/6498347 31929818
     [Google Scholar]
  146. Bansode VarshaJ. A review on pharmacological activities of Cinnamomum cassia Blume.Int J Green Pharm2012610210.4103/0973‑8258.102823
     [Google Scholar]
  147. JungY.H. KwonS.H. HongS.I. 5-HT1A receptor binding in the dorsal raphe nucleus is implicated in the anxiolytic-like effects of Cinnamomum cassia.Pharmacol. Biochem. Behav.2012103236737210.1016/j.pbb.2012.09.004 22982739
     [Google Scholar]
  148. YuH.S. LeeS.Y. JangC.G. Involvement of 5-HT1A and GABAA receptors in the anxiolytic-like effects of Cinnamomum cassia in mice.Pharmacol. Biochem. Behav.200787116417010.1016/j.pbb.2007.04.013 17512974
     [Google Scholar]
  149. EmamghoreishiM. KhasakiM. AazamM.F. Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze.J. Ethnopharmacol.200596336537010.1016/j.jep.2004.06.022 15619553
     [Google Scholar]
  150. MahendraP. BishtS. Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models.Indian J. Pharmacol.201143557457710.4103/0253‑7613.84975 22022003
     [Google Scholar]
  151. BarettaI.P. FelizardoR.A. BimbatoV.F. Anxiolytic-like effects of acute and chronic treatment with Achillea millefolium L. extract.J. Ethnopharmacol.20121401465410.1016/j.jep.2011.11.047 22155391
     [Google Scholar]
  152. LvJ.L. ZhangL.B. GuoL.M. Phthalide dimers from Angelica sinensis and their COX-2 inhibition activity.Fitoterapia201812910210710.1016/j.fitote.2018.06.016 29935258
     [Google Scholar]
  153. HasanM. PaulN.C. PaulS.K. Natural product-based potential therapeutic interventions of pulmonary fibrosis.Molecules2022275148110.3390/molecules27051481 35268581
     [Google Scholar]
  154. DengS. ChenS.N. LuJ. GABAergic phthalide dimers fromAngelica sinensis (Oliv.) Diels.Phytochem. Anal.200617639840510.1002/pca.937 17144247
     [Google Scholar]
  155. GrundmannO. NakajimaJ.I. SeoS. ButterweckV. Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test.J. Ethnopharmacol.2007110340641110.1016/j.jep.2006.09.035 17101250
     [Google Scholar]
  156. RochaF.F. LapaA.J. De LimaT.C.M. Evaluation of the anxiolytic-like effects of Cecropia glazioui Sneth in mice.Pharmacol. Biochem. Behav.2002711-218319010.1016/S0091‑3057(01)00695‑5 11812521
     [Google Scholar]
  157. IsholaI.O. OlayemiS.O. IdowuA.R. Anticonvulsant, anxiolytic and hypnotic effects of aqueous bulb extract of Crinum glaucum A. chev (Amaryllidaceae): Role of GABAergic and nitrergic systems.Pakistan J. Biol. Sci.20131615701710
     [Google Scholar]
  158. ZhangW. YanY. WuY. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.Pharmacol. Res.202217910620410.1016/j.phrs.2022.106204 35378276
     [Google Scholar]
  159. RamachandranS. Review on Sphaeranthus indicus Linn. (Koṭṭaikkarantai).Pharmacogn. Rev.201371415716910.4103/0973‑7847.120517 24347924
     [Google Scholar]
  160. XieW. MengX. ZhaiY. Panax notoginseng saponins: A review of its mechanisms of antidepressant or anxiolytic effects and network analysis on phytochemistry and pharmacology.Molecules201823494010.3390/molecules23040940 29673237
     [Google Scholar]
  161. SatyanK.S. JaiswalA.K. GhosalS. BhattacharyaS.K. Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba.Psychopharmacology1998136214815210.1007/s002130050550 9551771
     [Google Scholar]
  162. GuptaV. BansalP. KohliK. GhaiyeP. Anxiolytic effect of citrus paradisi var. Marsh seedless using different models.Int. Neuropsychiatr. Dis. J.20154310811310.9734/INDJ/2015/18699
     [Google Scholar]
  163. MoraS. Díaz-VélizG. MillánR. Anxiolytic and antidepressant-like effects of the hydroalcoholic extract from Aloysia polystachya in rats.Pharmacol. Biochem. Behav.200582237337810.1016/j.pbb.2005.09.007 16278011
     [Google Scholar]
  164. Hellión-IbarrolaM.C. IbarrolaD.A. MontalbettiY. The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice.J. Ethnopharmacol.2006105340040810.1016/j.jep.2005.11.013 16386395
     [Google Scholar]
  165. WangJ. WangL. LouG.H. Coptidis Rhizoma: A comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology.Pharm. Biol.201957119322510.1080/13880209.2019.1577466 30963783
     [Google Scholar]
  166. BigoniyaP. RanaA.C. Psychopharmacological profile of hydro-alcoholic extract of Euphorbia neriifolia leaves in mice and rats.Indian J. Exp. Biol.20054310859862 16235717
     [Google Scholar]
  167. SarrisJ. McIntyreE. CamfieldD.A. Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence.CNS Drugs201327430131910.1007/s40263‑013‑0059‑9 23653088
     [Google Scholar]
  168. AwadR. AhmedF. Bourbonnais-SpearN. Ethnopharmacology of Q’eqchi’ Maya antiepileptic and anxiolytic plants: Effects on the GABAergic system.J. Ethnopharmacol.2009125225726410.1016/j.jep.2009.06.034 19591913
     [Google Scholar]
  169. Hooi HoonA. Hung SeongC. Studies on the anxiolytic activity of Eurycoma longifolia Jack roots in mice.Jpn. J. Pharmacol.199979449750010.1254/jjp.79.497 10361892
     [Google Scholar]
  170. MartínezA.L. DomínguezF. OrozcoS. Neuropharmacological effects of an ethanol extract of the Magnolia dealbata Zucc. leaves in mice.J. Ethnopharmacol.2006106225025510.1016/j.jep.2006.01.003 16442760
     [Google Scholar]
  171. KuribaraH. KishiE. HattoriN. OkadaM. MaruyamaY. The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark.J. Pharm. Pharmacol.201052111425142910.1211/0022357001777432 11186252
     [Google Scholar]
  172. Jiménez-CabreraT. BautistaM. Velázquez-GonzálezC. Promising antioxidant activity of Erythrina genus: An alternative treatment for inflammatory pain?Int. J. Mol. Sci.202022124810.3390/ijms22010248 33383701
     [Google Scholar]
  173. ChuH.B. TanY.D. LiY.J. ChengB.B. RaoB.Q. ZhouL.S. Anxiolytic and anti-depressant effects of hydroalcoholic extract from Erythrina variegata and its possible mechanism of action.Afr. Health Sci.20191932526253610.4314/ahs.v19i3.28 32127825
     [Google Scholar]
  174. NagarajaT. MahmoodR. ThippeswamyB.S. VeerapurV.P. KrishnaV. Evaluation of anxiolytic effect of erythrina mysorensis gamb. in mice.Indian J. Pharmacol.201244448949210.4103/0253‑7613.99316 23087511
     [Google Scholar]
  175. Silveira-SoutoM.L. São-MateusC.R. de Almeida-SouzaL.M. GroppoF.C. Effect of Erythrinamu lungu on anxiety during extraction of third molars.Med. Oral Patol. Oral Cir. Bucal2014195e518e52410.4317/medoral.19511 24880443
     [Google Scholar]
  176. HawisetT. SriraksaN. KamsrijaiU. WanchaiK. InkaewP. Anxiolytic and antidepressant-like activities of aqueous extract of Azadirachta indica A. Juss. flower in the stressed rats.Heliyon202282e0888110.1016/j.heliyon.2022.e08881 35198760
     [Google Scholar]
  177. ShahrajabianM.H. SunW. SoleymaniA. ChengQ. Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses.Phytother. Res.20213531237124710.1002/ptr.6888 33350538
     [Google Scholar]
  178. SinghN. KaurS. BediP.M. KaurD. Anxiolytic effects of Equisetum arvense Linn. extracts in mice.Indian J. Exp. Biol.2011495352356 21615059
     [Google Scholar]
  179. LiuJ. LvY.W. ShiJ.L. Anti-anxiety effect of (−)-syringaresnol-4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside from albizzia julibrissin durazz (Leguminosae).Molecules2017228133110.3390/molecules22081331 28800105
     [Google Scholar]
  180. KumarV. SinghR.K. JaiswalA.K. BhattacharyaS.K. AcharyaS.B. Anxiolytic activity of Indian abies pindrow royle leaves in rodents: An experimental study.Indian J. Exp. Biol.2000384343346 11218810
     [Google Scholar]
  181. RabbaniM. SajjadiS.E. VaseghiG. JafarianA. Anxiolytic effects of Echium amoenum on the elevated plus-maze model of anxiety in mice.Fitoterapia200475545746410.1016/j.fitote.2004.04.004 15261383
     [Google Scholar]
  182. RabbaniM. SajjadiS.E. JafarianA. VaseghiG. Anxiolytic effects of Salvia reuterana Boiss. on the elevated plus-maze model of anxiety in mice.J. Ethnopharmacol.20051011-310010310.1016/j.jep.2005.03.034 15994042
     [Google Scholar]
  183. MoraS. MillánR. LungenstrassH. The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats.J. Ethnopharmacol.20061061768110.1016/j.jep.2005.12.004 16413718
     [Google Scholar]
  184. Herrera-RuizM. García-BeltránY. MoraS. Díaz-VélizG. VianaG.S.B. TortorielloJ. Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans.J. Ethnopharmacol.20061071535810.1016/j.jep.2006.02.003
     [Google Scholar]
  185. SaroyaA.S. SinghJ. Neuropharmacology of Scutellaria baicalensis Georgi.Pharmacother Potential Nat Prod Neurol Disord20188193
     [Google Scholar]
  186. EghbaliFeriz STaleghani A, Tayarani-Najaran Z. Central nervous system diseases and Scutellaria: A review of current mechanism studies.Biomed. Pharmacother.201810218519510.1016/j.biopha.2018.03.021 29554597
     [Google Scholar]
  187. HuiK.M. HuenM.S.Y. WangH.Y. Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi.Biochem. Pharmacol.20026491415142410.1016/S0006‑2952(02)01347‑3 12392823
     [Google Scholar]
  188. LimanaqiF. BiagioniF. BuscetiC.L. PolzellaM. FabriziC. FornaiF. Potential antidepressant effects of Scutellaria baicalensis, Hericium erinaceus and Rhodiola rosea.Antioxidants20209323410.3390/antiox9030234 32178272
     [Google Scholar]
  189. ZhangL.L. YangZ.Y. FanG. RenJ.N. YinK.J. PanS.Y. Antidepressant-like effect of Citrus sinensis (L.) osbeck essential oil and its main component limonene on mice.J. Agric. Food Chem.20196750138171382810.1021/acs.jafc.9b00650 30905156
     [Google Scholar]
  190. HattesohlM. FeistelB. SieversH. LehnfeldR. HeggerM. WinterhoffH. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.Phytomedicine2008151-221510.1016/j.phymed.2007.11.027 18160026
     [Google Scholar]
  191. OlivaI. González-TrujanoM.E. ArrietaJ. Enciso-RodríguezR. NavarreteA. Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice.Phytother. Res.200418429029610.1002/ptr.1389 15162363
     [Google Scholar]
  192. RaihanM.O. HabibM.R. BrishtiA. RahmanM.M. SaleheenM.M. MannaM. Sedative and anxiolytic effects of the methanolic extract of Leea indica (Burm. f.) Merr. leaf.Drug Discov. Ther.20115418518910.5582/ddt.2011.v5.4.185 22466299
     [Google Scholar]
  193. Akhtar AliM. TauheedA. AliA. Recent trend in traditional medicine dosage form and present status of unani and ayurvedic medicine need to cite this paper? want more papers like this? recent trend in traditional medicine dosage form and present status of unani and ayurvedic medicine.Int. J. Pharm. Sci. Res.20191041640[Internet]10.13040/IJPSR.0975‑8232.10
     [Google Scholar]
  194. AnandU. TuduC.K. NandyS. Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectives – A review.J. Ethnopharmacol.202228411474410.1016/j.jep.2021.114744 34656666
     [Google Scholar]
  195. KaurDivneet KambojAnjoo ShriRicha Comparative evaluation of anxiolytic effects of various extracts of oats (Avena sativa), rice bran (oryza sativa) and spinach (Spinacia oleracea) in experimental animals.Int. J. Pharm. Sci. Res.201941104116
     [Google Scholar]
  196. JohncoC.J. SalloumA. LewinA.B. McBrideN.M. StorchE.A. The impact of comorbidity profiles on clinical and psychosocial functioning in childhood anxiety disorders.Psychiatry Res.20152291-223724410.1016/j.psychres.2015.07.027 26205632
     [Google Scholar]
  197. EmslieG.J. Pediatric anxiety--underrecognized and undertreated.N. Engl. J. Med.2008359262835283610.1056/NEJMe0809401 19109579
     [Google Scholar]
  198. FavaG.A. PorcelliP. RafanelliC. MangelliL. GrandiS. The spectrum of anxiety disorders in the medically ill.J. Clin. Psychiatry201071791091410.4088/JCP.10m06000blu 20584526
     [Google Scholar]
/content/journals/cprr/10.2174/0126660822265289240306175345
Loading
Anxiety: Its Management, Treatment, and Alternative Complementary Medicine
Curr Psyc Res Rev 21, 229 (2025); https://doi.org/10.2174/0126660822265289240306175345
/content/journals/cprr/10.2174/0126660822265289240306175345
/content/journals/cprr/10.2174/0126660822265289240306175345
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): allopathy treatment; alternative therapy; Anxiety disorder; complementary medicine; herbal treatment; management

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test